Safety and efficacy of simvastatin for hyperlipidemia in renal transplant recipients: a double-blind, randomized, placebo-controlled study.
Santa Casa Hospital and Post-Graduation in Nephrology from PUC-RS, Brazil.
A F
AF
Santos
E
E
Keitel
A E
AE
Bittar
J
J
Neumann
F D
FD
Fuchs
J C
JC
Goldani
N A
NA
Fonseca
V C
VC
Prates
D
D
Zaffan
C
C
Voegeli
L
L
Kroth
G
G
Steffenello
D
D
Saitovitch
V D
VD
Garcia
D000328:Adult; D000704:Analysis of Variance; D002784:Cholesterol / Q000097:blood; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D019821:Simvastatin / Q000009:adverse effects / Q000627:therapeutic use*
D000960:Hypolipidemic Agents; D007166:Immunosuppressive Agents; D002784:Cholesterol; D019821:Simvastatin